European Archives - Page 196 of 1318 - European Medical Journal

Financial Toxicity: An Overlooked Driver of Heart Failure Risk in the USA

Heart failure is responsible not only for high morbidity and mortality, but also for significant out-of-pocket expenses for patients…

EMJ Hepatology 13 [Supplement 2] 2025

Primary biliary cholangitis (PBC) experts Thomas Berg, Michael Trauner, and Palak Trivedi discuss the current unmet needs in PBC…

West Nile Virus found in UK mosquitoes for first time

Experts have pointed to the climate crisis as a potential trigger of the West Nile Virus finding.

Causes of Death in Metabolic Dysfunction-Associated Liver Disease

A recent nationwide Swedish cohort study involving over 13,000 patients with MASLD compared mortality rates and causes of death.

Medical affairs: What's working for HCPs in 2025

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

Study Identifies Flare Risk in Rheumatoid Arthritis Remission

The UK BIO-FLARE study finds that half of rheumatoid arthritis patients relapse after stopping medication, with flare risk predicted by baseline clinical factors.

EuroPCR 2025: Less Bleeding after PCI with Short DAPT and Prasugrel in Acute Coronary Syndrome

Shorter dual antiplatelet therapy followed by low-dose prasugrel cuts bleeding risk after PCI, new trial shows.

Whole Genome Sequencing Breakthrough for Cancer of Unknown Origin

Whole genome and transcriptome sequencing (WGTS) outperforms standard gene panels in diagnosing cancer of unknown origin, offering clearer tissue-of-origin insights and broader treatment options, according to new research.

Effects of Wild-Food Diet on Gut Microbiome Diversity

Results showed that the wild-food diet led to significant alterations in the gut microbiome, exceeding changes seen in previous dietary interventions.

Evolving Strategies in Lupus Care

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that remains challenging to diagnose and treat. In this interview…